Biomarin Pharmaceutical (BMRN) FCF Margin Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.52 Bn |
8.29 Bn |
571.21 Mn |
4,256.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,256.00 |
| Dec 31, 2025 |
1,211.00 |
| Sep 30, 2025 |
1,831.00 |
| Jun 30, 2025 |
1,493.00 |
| Mar 31, 2025 |
3,545.00 |
| Dec 31, 2024 |
2,613.00 |
| Sep 30, 2024 |
806.00 |
| Jun 30, 2024 |
169.00 |
| Mar 31, 2024 |
-1,489.00 |
| Dec 31, 2023 |
960.00 |
| Sep 30, 2023 |
499.00 |
| Jun 30, 2023 |
778.00 |
| Mar 31, 2023 |
-539.00 |
| Dec 31, 2022 |
-682.00 |
| Sep 30, 2022 |
1,745.00 |
| Jun 30, 2022 |
2,014.00 |
| Mar 31, 2022 |
657.00 |
| Dec 31, 2021 |
-597.00 |
| Sep 30, 2021 |
1,984.00 |
| Jun 30, 2021 |
2,712.00 |
